For the quarter ended December 2025, Integer (ITGR) reported revenue of $472.06 million, up 5% over the same period last year. EPS came in at $1.76, compared to $1.43 in the year-ago quarter.
The reported revenue represents a surprise of +2.04% over the Zacks Consensus Estimate of $462.63 million. With the consensus EPS estimate being $1.70, the EPS surprise was +3.62%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Integer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:- Sales- Medical Sales- Other Markets: $20.55 million versus $16.59 million estimated by five analysts on average.
- Sales- Medical Sales- Cardio & Vascular: $284.21 million versus the five-analyst average estimate of $274.01 million. The reported number represents a year-over-year change of +11.3%.
- Sales- Medical Sales- Cardiac Rhythm Management & Neuromodulation: $167.3 million versus $172.57 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -1.9% change.
View all Key Company Metrics for Integer here>>>
Shares of Integer have returned -0.6% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpInteger Holdings Corporation (ITGR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
